2026 BIMS Lab Coat Ceremony and Reception
3/31/2026
Please plan to join us as we celebrate first-year BIMS students receiving their lab coats. Students will be coated by their mentors. The ceremony will be followed by a reception…
Date: Apr 17, 2026 - Apr 17, 2026
Start Time: 5:30 pm
End Time: 7:30 pm
Food Trucks at Fontaine Research Park
3/30/2026
Food trucks are now rolling into Fontaine Research Park, bringing a rotating lineup of fresh, local flavors. It’s an easy way to grab lunch, try something new, and enjoy a…
Date: Mar 26, 2026 - Apr 30, 2026
3/30/2026
The New York Times interviews Jeff Wilson, MD, PhD, an assistant professor in the Department of Medicine, Division of Allergy and Immunology, about alpha-gal syndrome, a meat allergy caused by…
UVA Health Leadership Institute Applications Open, Info Session April 7
3/30/2026
Applications for cohort five of the UVA Health Leadership Institute’s (HLI) cohort leadership program are now open. Interested candidates should complete their application, essay, and submit a letter of recommendation via the HLI application…
Nominate a Colleague for the Jefferson Awards
3/30/2026
The Thomas Jefferson Awards are the highest honor given to members of the University community who have exemplified the principles, ideals, and mission of the University, in their character, work,…
Kratom Calls Skyrocket to Nation’s Poison Centers
3/30/2026
Calls to poison centers about kratom, a drug widely available in vape shops and gas stations, increased more than 1,200% between 2015 and 2025, with a corresponding rise in hospitalizations,…
New AI Approach to Speed Drug Development
3/30/2026
University of Virginia School of Medicine scientists have developed a bold new approach to drug discovery that could dramatically accelerate the creation of new medicines. UVA’s Nikolay V. Dokholyan, PhD,…
Research in Motion: Matthew Reilley, MD
3/30/2026
My research focus is primarily on running clinical trials for patients with cancer. My main focus in the clinic is seeing patients with gastrointestinal cancer and offering them trials, but…
